The Oncology Institute, Inc. (TOI)
TOI Stock Price Chart
Explore The Oncology Institute, Inc. interactive price chart. Choose custom timeframes to analyze TOI price movements and trends.
TOI Company Profile
Discover essential business fundamentals and corporate details for The Oncology Institute, Inc. (TOI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
4 Jun 2020
Employees
825.00
Website
https://theoncologyinstitute.comCEO
Daniel Virnich
Description
The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.
TOI Financial Timeline
Browse a chronological timeline of The Oncology Institute, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.07, while revenue estimate is $155.21m.
Earnings released on 7 May 2026
EPS came in at -$0.02 surpassing the estimated -$0.07 by +71.43%, while revenue for the quarter reached $147.44m , beating expectations by +3.76%.
Earnings released on 12 Mar 2026
EPS came in at -$0.06 surpassing the estimated -$0.08 by +25.00%, while revenue for the quarter reached $141.96m , beating expectations by +1.55%.
Earnings released on 13 Nov 2025
EPS came in at -$0.14 falling short of the estimated -$0.12 by -16.67%, while revenue for the quarter reached $136.56m , missing expectations by -2.30%.
Earnings released on 13 Aug 2025
EPS came in at -$0.14 matching the estimated -$0.14, while revenue for the quarter reached $119.80m , missing expectations by -2.24%.
Earnings released on 14 May 2025
EPS came in at -$0.17 , while revenue for the quarter reached $104.41m .
Earnings released on 24 Mar 2025
EPS came in at -$0.14 falling short of the estimated -$0.08 by -75.00%, while revenue for the quarter reached $100.27m , missing expectations by -8.14%.
Earnings released on 13 Nov 2024
EPS came in at -$0.18 falling short of the estimated -$0.07 by -157.14%, while revenue for the quarter reached $99.90m , missing expectations by -7.11%.
Earnings released on 13 Aug 2024
EPS came in at -$0.17 falling short of the estimated -$0.10 by -70.00%, while revenue for the quarter reached $98.58m , missing expectations by -4.58%.
Earnings released on 14 May 2024
EPS came in at -$0.22 falling short of the estimated -$0.12 by -83.33%, while revenue for the quarter reached $94.67m , missing expectations by -0.52%.
Earnings released on 27 Mar 2024
EPS came in at -$0.21 falling short of the estimated -$0.11 by -90.91%, while revenue for the quarter reached $85.79m , beating expectations by +4.57%.
Earnings released on 8 Nov 2023
EPS came in at -$0.19 falling short of the estimated -$0.13 by -46.15%, while revenue for the quarter reached $82.04m , missing expectations by -0.01%.
Earnings released on 8 Aug 2023
EPS came in at -$0.19 falling short of the estimated -$0.17 by -11.76%, while revenue for the quarter reached $80.22m , beating expectations by +5.29%.
Earnings released on 10 May 2023
EPS came in at -$0.10 surpassing the estimated -$0.17 by +41.18%, while revenue for the quarter reached $76.19m , beating expectations by +17.22%.
Earnings released on 9 Mar 2023
EPS came in at -$0.16 surpassing the estimated -$0.18 by +11.11%, while revenue for the quarter reached $71.42m , beating expectations by +10.31%.
Earnings released on 9 Nov 2022
EPS came in at -$0.17 falling short of the estimated -$0.16 by -6.25%, while revenue for the quarter reached $64.98m , missing expectations by -5.77%.
Earnings released on 9 Aug 2022
EPS came in at -$0.06 , while revenue for the quarter reached $60.92m .
Earnings released on 11 May 2022
EPS came in at -$0.29 , while revenue for the quarter reached $55.16m .
Earnings released on 10 Mar 2022
EPS came in at $0.26 , while revenue for the quarter reached $52.30m .
Earnings released on 8 Nov 2021
EPS came in at -$0.04 , while revenue for the quarter reached $52.28m .
Earnings released on 16 Aug 2021
EPS came in at $0.05 , while revenue for the quarter reached $49.84m .
TOI Stock Performance
Access detailed TOI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
